Zomedica Strengthens Executive Leadership Team

July 10, 2017

ANN ARBOR, Mich., July 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that Bruk Herbst has joined the company as Chief Commercial Officer. In this new company position, he is responsible for delivering and executing Zomedica’s commercial strategy, as well as leading the company’s… [ READ MORE ]

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

June 20, 2017

ANN ARBOR, Mich., June 20, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at The MicroCap Conference, on Tuesday, June 27 at the Sheraton Centre Hotel in Toronto, Canada. Chief Executive Officer Gerald Solensky Jr. will provide an overview of Zomedica’s… [ READ MORE ]

Zomedica Announces 2017 Annual Meeting Results

June 2, 2017

ANN ARBOR, Mich., June 2, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, is pleased to announce that all ordinary and special resolutions were passed at the Annual and Special Meeting of Shareholders, which was held today in Toronto, Ontario, Canada. An aggregate of… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

May 11, 2017

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three months ended March 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International Financial Reporting… [ READ MORE ]

Zomedica Announces Adoption of Advance Notice Bylaw

April 28, 2017

ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, announces the adoption of an advance notice bylaw (the “Advance Notice Bylaw”). The Advance Notice Bylaw includes, among other things, a provision that requires advance notice to be given to the… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

April 24, 2017

ANN ARBOR, Mich., April 24, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) on Form S-1 relating to the resale or other disposition by selling shareholders of up to… [ READ MORE ]

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

April 10, 2017

ANN ARBOR, Mich., April 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM), a veterinary pharmaceutical company and health care solutions company, today announced the closing of the second and final tranche of its previously announced non-brokered private placement offering of common shares (each a “Common Share”) at a price of C$1.50 per Common… [ READ MORE ]

Zomedica Announces Ongoing Equity Financing

March 7, 2017

ANN ARBOR, Mich., March 07, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that its previously announced non-brokered private placement offering of up to 6,657,520 Common Shares at a price of C$1.50 per Common Share (each a “Common Share”) is ongoing. The first tranche of… [ READ MORE ]